Skip to main content

Use and impact of molecular methods for detecting drug‐resistant TB

Buy Article:

$24.29 + tax (Refund Policy)

No Abstract

Document Type: Letter to the Editor

Affiliations: 1: Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias (CIBERES), Badalona, Spain 2: Unité 1135, Institut National de la Santé et de la Recherche Médicale, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Paris, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Hôpital Pitié-Salpêtrière, Groupe Hospitalier Universitaire Sorbonne Université, Assistanve Publique-Hôpitaux de Paris, Paris, France 3: Department of Respiratory Medicine, Homerton University Hospital, Queen Mary University, London, London School of Hygiene & Tropical Medicine, London, UK 4: Department of Global Health, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands 5: Divisions of Clinical Infectious Diseases, Research Center Borstel, German Center for Infection Research (DZIF), Clinical Tuberculosis Unit, Borstel, Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany

Publication date: February 1, 2021

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content